Home › Biblio

Biblio

Found 62 results

2011
DeZern AE, Sung A, Kim S, Smith DB, Karp JE, Gore SD, Jones RJ, Fuchs E, Luznik L, McDevitt M et al..  2011.  Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(9):1404-9. Abstract
Henderson CF, Brodsky RA, Jones RJ, Levine SM.  2011.  High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.. Seminars in arthritis and rheumatism. 41(2):301-4. Abstract
Bolaños-Meade J, Smith DB, Gore SD, McDevitt MA, Luznik L, Fuchs EJ, Jones RJ.  2011.  5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):754-8. Abstract
Kasamon YL, Jones RJ, Gocke CD, Blackford AL, Seifter EJ, Davis-Sproul JM, Gore SD, Ambinder RF.  2011.  Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):365-73. Abstract
DeZern AE, Petri M, Drachman DB, Kerr D, Hammond ER, Kowalski J, Tsai H-L, Loeb DM, Anhalt G, Wigley F et al..  2011.  High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.. Medicine. 90(2):89-98. Abstract
Gerber JM, Qin L, Kowalski J, Smith DB, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W et al..  2011.  Characterization of chronic myeloid leukemia stem cells.. American journal of hematology. 86(1):31-7. Abstract
Smith DB, Jones RJ, Cho E, Kowalski J, Karp JE, Gore SD, Vala M, Meade B, Baker SD, Zhao M et al..  2011.  Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF.. Leukemia research. 35(1):87-94. Abstract
2010
Luznik L, Jones RJ, Fuchs EJ.  2010.  High-dose cyclophosphamide for graft-versus-host disease prevention.. Current opinion in hematology. 17(6):493-9. Abstract
Petri M, Brodsky RA, Jones RJ, Gladstone D, Fillius M, Magder LS.  2010.  High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial.. Arthritis and rheumatism. 62(5):1487-93. Abstract
Brodsky RA, Chen AR, Dorr D, Fuchs EJ, Huff CA, Luznik L, Smith DB, Matsui WH, Goodman SN, Ambinder RF et al..  2010.  High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.. Blood. 115(11):2136-41. Abstract
Karp JE, Blackford A, Smith DB, Alino K, Seung AH, Bolaños-Meade J, Greer JM, Carraway HE, Gore SD, Jones RJ et al..  2010.  Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.. Leukemia research. 34(7):877-82. Abstract
Luznik L, Bolaños-Meade J, Zahurak M, Chen AR, Smith DB, Brodsky R, Huff CA, Borrello I, Matsui W, Powell JD et al..  2010.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.. Blood. 115(16):3224-30. Abstract
Symons HJ, Leffell SM, Rossiter ND, Zahurak M, Jones RJ, Fuchs EJ.  2010.  Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):533-42. Abstract
Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai H-L, Bolaños-Meade J, Morris LE, Crilley PA, O'Donnell PV, Rossiter N et al..  2010.  Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):482-9. Abstract
Sharrow AC, Ronnett BM, Thoburn CJ, Barber JP, Giuntoli RL, Armstrong DK, Jones RJ, Hess AD.  2010.  Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats.. Journal of ovarian research. 3:9. Abstract
Brennan SK, Wang Q, Tressler R, Harley C, Go N, Bassett E, Huff CA, Jones RJ, Matsui W.  2010.  Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms.. PloS one. 5(9) Abstract
2009
Jones RJ.  2009.  Cancer stem cells-clinical relevance.. Journal of molecular medicine (Berlin, Germany). 87(11):1105-10. Abstract
Emadi A, Jones RJ, Brodsky RA.  2009.  Cyclophosphamide and cancer: golden anniversary.. Nature reviews. Clinical oncology. 6(11):638-47. Abstract
Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, Vala MS, Gerber JM, Gellert LL, Siedner M et al..  2009.  Circulating clonotypic B cells in classic Hodgkin lymphoma.. Blood. 113(23):5920-6. Abstract
Savage WJ, Barber JP, Mukhina GL, Hu R, Chen G, Matsui W, Thoburn C, Hess AD, Cheng L, Jones RJ et al..  2009.  Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.. Experimental hematology. 37(1):42-51. Abstract
Kasamon YL, Wahl RL, Ziessman HA, Blackford AL, Goodman SN, Fidyk CA, Rogers KM, Bolaños-Meade J, Borowitz MJ, Ambinder RF et al..  2009.  Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(2):242-8. Abstract
Huang Y, Stewart TM, Wu Y, Baylin SB, Marton LJ, Perkins B, Jones RJ, Woster PM, Casero RA.  2009.  Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(23):7217-28. Abstract
Hu R, Mukhina GL, Lee SH, Jones RJ, Englund PT, Brown P, Sharkis SJ, Buckley TJ, Brodsky RA.  2009.  Silencing of genes required for glycosylphosphatidylinositol anchor biosynthesis in Burkitt lymphoma.. Experimental hematology. 37(4):423-434.e2. Abstract
2008
Warlick ED, O'Donnell PV, Borowitz M, Grupka N, Decloe L, Garrett-Mayer E, Borrello I, Brodsky R, Fuchs E, Huff CA et al..  2008.  Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.. Leukemia research. 32(9):1439-47. Abstract
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell SM, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF et al..  2008.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(6):641-50. Abstract

Your Support is the Key

Submitted by admin on May 9, 2011 - 11:20am

Matthew Slattery

Help children like Matthew unlock their potential by becoming a Partner in Potential.

Donate Learn More